3-Year anniversary of DEA’s policy change and no action

On August 12, 2016, the Drug Enforcement Administration (DEA) promised to open up a licensing process for American entities seeking to cultivate cannabis for scientific research purposes. Biopharmaceutical Research Company (BRC) is one of 25+ applicants who applied for a license back in 2016. Today, on the third anniversary of the DEA accepting applications for cultivation for research, the DEA still has yet to process BRC’s application, or any of the other 25 applications it received for this program. Read more →